RYTM — Rhythm Pharmaceuticals, Inc. | XLV Holdings | StockAdder

(RYTM)

Rhythm Pharmaceuticals, Inc.

Live chart and latest RYTM stock news.

Sector ETF → XLV Health Care Select

Chart powered byTradingView— professional charts for every trader.Try it free →

RYTM News

Is Rhythm Pharmaceuticals (RYTM) Still Attractive After A 48.9% One‑Year Share Price Gain

Apr 12, 2026 Stock Titan

Rhythm sets May 5 earnings call, CFO due at Needham event

Apr 9, 2026 Yahoo Finance

Rhythm Pharmaceuticals (RYTM) PT Increased From $136 to $143 at Wells Fargo on IMCIVREE Launch Optimism

Mar 18, 2026 qz.com

Strength Seen in Rhythm Pharmaceuticals (RYTM): Can Its 12.6% Jump Turn into More Strength?

Apr 1, 2026 Seeking Alpha

Rhythm Pharmaceuticals, Inc. (RYTM) Discusses FDA Approval of IMCIVREE for Acquired Hypothalamic Obesity - Slideshow (NASDAQ:RYTM) 2026-03-24

Mar 24, 2026 Sahm

Assessing Rhythm Pharmaceuticals (RYTM) Valuation After A Recent Share Price Pullback

Apr 13, 2026 Yahoo Finance

How The Rhythm Pharmaceuticals RYTM Story Is Shifting With Imcivree Revenue And New Targets

Feb 18, 2026 Stock Titan

Rhythm Pharmaceuticals (RYTM) EVP converts RSUs, now holding 66,030 shares

Apr 3, 2026 Yahoo Finance

A Look At Rhythm Pharmaceuticals (RYTM) Valuation After Recent Share Weakness And Strong Long Term Returns

Mar 18, 2026 Stock Titan

RHYTHM (RYTM) director receives 6,808 RSUs and 10,257 stock options

Apr 3, 2026 Yahoo Finance

A Look At Rhythm Pharmaceuticals (RYTM) Valuation After Recent Pullback In Share Price

Mar 1, 2026 Stock Titan

Rhythm Pharmaceuticals (RYTM) director Kimberly Popovits files initial Form 3

Apr 3, 2026 Yahoo Finance

Strength Seen in Rhythm Pharmaceuticals (RYTM): Can Its 12.6% Jump Turn into More Strength?

Apr 1, 2026 Stock Titan

Biotech veteran Kim Popovits joins Rhythm board as Ed Mathers leaves

Apr 3, 2026 Yahoo Finance

Rhythm Pharmaceuticals (RYTM) Reports Phase 3 EMANATE Trial Topline Results for Setmelanotide